Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiofarma is a Netherlands-based pharmaceutical company that operates as a specialized Contract Development and Manufacturing Organization (CDMO) and a developer of niche generic products. Founded in 1994, the company focuses on the production of semi-solids, liquids, and solid dosage forms, with a particular emphasis on dermatological treatments and orphan drugs. Tiofarma provides comprehensive services including formulation development, clinical trial material manufacturing, and commercial-scale production. Their business model targets high-complexity, low-volume products that require specialized manufacturing expertise, often stepping in to produce essential medicines that larger firms have discontinued. The company is a key supplier for the Dutch and European markets, ensuring patient access to specialized and essential medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tiofarma.